Quality nucleusA useful first conversation does not require a finished dossier or an exhaustive presentation. It does require a clear decision, a bounded opportunity, and honest disclosure of what is known, unknown, available, and still assumed.
Define the decision
State the decision your organization needs to make next. Examples include whether to qualify a manufacturer, test a private-label concept, assess a device pathway, redesign an operating workflow, or map an evidence gap. A broad request for ‘all information’ makes prioritization difficult.
Separate the immediate decision from later ambitions. This keeps the first assessment proportionate and makes it easier to identify the evidence that can genuinely change the decision.
- Decision required and decision owner
- Target date and dependencies
- What a useful output should contain
Describe the opportunity
Identify the product, dosage form, intended purpose, service, workflow, technology, or market access question with enough specificity to avoid category assumptions.
Include target geography, users or customers, channel, expected volume range, commercial model, and important exclusions. For regulated products, proposed claims and the identity of the legal manufacturer or authorization holder are particularly important.
- Product or service profile
- Target market and channel
- Intended users, use, and claims
- Indicative volume and economic constraints
Inventory the evidence
List the documents and facts already available without implying that they are current, complete, or authority-approved. A document index is often more useful than an uncontrolled archive.
Highlight contradictions and missing ownership. Do not send patient records, personal identifiers, financial credentials, or unnecessary trade secrets through the public Website.
- Manufacturer and site records
- Specifications, labels, and claims
- Quality, technical, testing, or stability evidence
- Licences, registrations, or written authority correspondence
- Known gaps and responsible party